Cargando…
Using Clinical Databases to Verify the Impact of Regulatory Agency Alerts in Japan: Hepatitis B Testing Behavior After an Alert Regarding Risk of Viral Reactivation
BACKGROUND: Measures of the effectiveness of risk minimization activities are necessary for the appropriate use of drugs, and clinical databases are a low-cost method of quickly producing such results. OBJECTIVE: The aim of this study was to explore the secondary application of clinical databases in...
Autores principales: | Udagawa, Yukio, Ohno, Shinya, Nakagawa, Shintaro, Sugimoto, Kazutaka, Mochizuki, Joji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883216/ https://www.ncbi.nlm.nih.gov/pubmed/27747569 http://dx.doi.org/10.1007/s40801-015-0034-5 |
Ejemplares similares
-
Functional status in the COVID-19 era: ALERT, ALERT, ALERT!
por: Marques, A.
Publicado: (2021) -
Characteristics of drug safety alerts issued by the Spanish Medicines Agency
por: Montané, Eva, et al.
Publicado: (2023) -
The Immunization Alert™
por: Jekel, James F.
Publicado: (1988) -
Paper Alert
por: Messing, Edward M.
Publicado: (2016) -
Paper Alert
por: Messing, Edward M.
Publicado: (2016)